Abstract
Classical swine fever virus (CSFV) causes significant losses in pig industry in many countries. The E2 glycoprotein of CSFV is the main target for inducing neutralizing antibodies and protective immunity in the natural host. In this study, one recombinant baculoviruses BacSC-E2 expressing histidine-tagged E2 with the CTD and TM derived from baculovirus envelope protein gp64 was constructed and evaluated its vaccine efficacy in mice model. After infection, E2 was expressed and anchored on the plasma membrane of Sf-9 cells, as revealed by confocal microscopy. Immunogold electron microscopy demonstrated that the BacSC-E2 was displayed E2 glycoprotein on the viral surface. Animal vaccine tests showed that BacSC-E2 elicited significantly higher E2 antibody titers in the treated mouse models than the control group. Virus neutralization test showed that serum from the BacSC-E2 treated models had significant levels of virus neutralization activities. This demonstrates that the BacSC-E2 vaccine can be a potential vaccine against CSFV infections. This is the first report demonstrating that the potential of E2-pseudotyped baculovirus as a classical swine fever virus vaccine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
